Image For Activity Cover
Best Practices: Managing and Diagnosing Hypophosphatemia
Course Description
Course Modules:
  • Differential Diagnosis of Hypophosphatemic Disorders
  • Mechanism of FGF23-Mediated Related Diseases
  • Clinical Evaluation and Management of Pediatric Patients with Hypophosphatemic Disorders
  • Clinical Evaluation and Management of Adult Patients with Hypophosphatemic Disorders
  • New Approaches to Tumor Induced Osteomalacia
This program was funded through educational grants from Ultragenyx. Each recording will include 3-5 pre- and post-test questions and an activity evaluation to receive credit and a certificate.
Target Audience
This activity is intended for endocrinologists and endocrine fellows, primary care physicians, physician’s assistants, nurse practitioners and other healthcare professionals.
Learning Objectives

Upon completion of this educational activity, learners will be able to:

  • Identify optimal approaches to effectively evaluate pediatric and adult patients with hypophosphatemia.
  • Discuss treatment strategies for hypophosphatemic disorders in adult and pediatric patients
Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 5.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC) - if eligible
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 5.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at

Successful completion of components two and three of this five-part CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points in the American Board of Pediatrics (ABP) Maintenance of Certification (MOC) program, for each of the two eligible webinars. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit. 

Faculty and Disclosures

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Laila S. Tabatabai, MD: Speaker: Radius, Amgen; Research Investigator: Ultragenyx Pharmaceuticals
Michael T. Collins, MD: Research Grant Support: NPS/Shire/Takeda, QED Therapeutics
Pablo Florenzano, MD:  Speaker, Ultragenyx Pharmaceuticals; Research, Ultragenyx Pharmaceuticals; Advisory Board Member, Kyowa Kirin 
Rachel I. Gafni, MD:  Research Investigator: Ultragenyx Pharmaceuticals, QED Therapeutics, Inozyme
Erik A. Imel, MD: Research Funding, Ultragenyx Pharmaceuticals, Pharmacosmos.  Advisory Board, Ultragenyx Pharmaceuticals, Pharmacosmos
Suzanne Jan De Beur, MD: Research Support, Ultragenyx Pharmaceutical, Mereo Biopharma; Advisory Board,  Ultragenyx Pharmaceutical, Kyowa Kirin; Consultant, Ultragenyx Pharmaceutical

The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships:
Deborah Sellmeyer, MD

The following SPC Committee members reported relevant financial relationships:
Andjela T. Drincic, MD: Advisory Board Member, Corcept
Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Akcea, Aegerion, Esperion, Novartis
Angela M. Leung, MD: Speaker, Medical Education Resources, MCE Conferences
Amy Rothberg, MD: Spouse, consultant of Merck

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:
Katherine Araque, MD; Beret Ann Casey, MD; Jenny Blau, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD

The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

This educational activity is supported by educational grants from Ultragenyx.

Availability: On-Demand
Available Aug 17, 2020 to Dec 31, 2021
Cost : FREE
Credit Offered:
5 AMA PRA Category 1 Credits
5 ABIM-MOC Points
2 ABP-MOC Points
5 Participation Credits
Contains: 5 Courses
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Powered By